Global Cancer Targeted Drug Supply, Demand and Key Producers, 2024-2030

Description

The global Cancer Targeted Drug market size is expected to reach $ 93860 million by 2030, rising at a market growth of 8.9% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Targeted therapy is a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.

This report studies the global Cancer Targeted Drug demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cancer Targeted Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cancer Targeted Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cancer Targeted Drug total market, 2019-2030, (USD Million)
Global Cancer Targeted Drug total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Cancer Targeted Drug total market, key domestic companies and share, (USD Million)
Global Cancer Targeted Drug revenue by player and market share 2019-2024, (USD Million)
Global Cancer Targeted Drug total market by Type, CAGR, 2019-2030, (USD Million)
Global Cancer Targeted Drug total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Cancer Targeted Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Eisai, Zelgen, Cipla, Natco Pharma, AstraZeneca, Novartis, Roche and Bristol-Myers Squibb, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cancer Targeted Drug market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Cancer Targeted Drug Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cancer Targeted Drug Market, Segmentation by Type
    Sorafenib
    Lenvatinib
    Regorafenib
    Osimertinib
    Anlotinib
    Alectinib
    Other

Global Cancer Targeted Drug Market, Segmentation by Application
    Hospital
    Retail Pharmacy
    Other

Companies Profiled:
    Bayer
    Eisai
    Zelgen
    Cipla
    Natco Pharma
    AstraZeneca
    Novartis
    Roche
    Bristol-Myers Squibb
    Pfizer
    BEACON Pharma
    Jiangxi Shanxiang
    Yao Pharma
    CSPC
    CHIATAI Tianqing
    Simcere

Key Questions Answered
1. How big is the global Cancer Targeted Drug market?
2. What is the demand of the global Cancer Targeted Drug market?
3. What is the year over year growth of the global Cancer Targeted Drug market?
4. What is the total value of the global Cancer Targeted Drug market?
5. Who are the major players in the global Cancer Targeted Drug market?

Table of Contents

1 Supply Summary
    1.1 Cancer Targeted Drug Introduction
    1.2 World Cancer Targeted Drug Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Cancer Targeted Drug Total Market by Region (by Headquarter Location)
        1.3.1 World Cancer Targeted Drug Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Cancer Targeted Drug Market Size (2019-2030)
        1.3.3 China Cancer Targeted Drug Market Size (2019-2030)
        1.3.4 Europe Cancer Targeted Drug Market Size (2019-2030)
        1.3.5 Japan Cancer Targeted Drug Market Size (2019-2030)
        1.3.6 South Korea Cancer Targeted Drug Market Size (2019-2030)
        1.3.7 ASEAN Cancer Targeted Drug Market Size (2019-2030)
        1.3.8 India Cancer Targeted Drug Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cancer Targeted Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Cancer Targeted Drug Major Market Trends

2 Demand Summary
    2.1 World Cancer Targeted Drug Consumption Value (2019-2030)
    2.2 World Cancer Targeted Drug Consumption Value by Region
        2.2.1 World Cancer Targeted Drug Consumption Value by Region (2019-2024)
        2.2.2 World Cancer Targeted Drug Consumption Value Forecast by Region (2025-2030)
    2.3 United States Cancer Targeted Drug Consumption Value (2019-2030)
    2.4 China Cancer Targeted Drug Consumption Value (2019-2030)
    2.5 Europe Cancer Targeted Drug Consumption Value (2019-2030)
    2.6 Japan Cancer Targeted Drug Consumption Value (2019-2030)
    2.7 South Korea Cancer Targeted Drug Consumption Value (2019-2030)
    2.8 ASEAN Cancer Targeted Drug Consumption Value (2019-2030)
    2.9 India Cancer Targeted Drug Consumption Value (2019-2030)

3 World Cancer Targeted Drug Companies Competitive Analysis
    3.1 World Cancer Targeted Drug Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cancer Targeted Drug Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cancer Targeted Drug in 2023
        3.2.3 Global Concentration Ratios (CR8) for Cancer Targeted Drug in 2023
    3.3 Cancer Targeted Drug Company Evaluation Quadrant
    3.4 Cancer Targeted Drug Market: Overall Company Footprint Analysis
        3.4.1 Cancer Targeted Drug Market: Region Footprint
        3.4.2 Cancer Targeted Drug Market: Company Product Type Footprint
        3.4.3 Cancer Targeted Drug Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Cancer Targeted Drug Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cancer Targeted Drug Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Cancer Targeted Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Cancer Targeted Drug Consumption Value Comparison
        4.2.1 United States VS China: Cancer Targeted Drug Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Cancer Targeted Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Cancer Targeted Drug Companies and Market Share, 2019-2024
        4.3.1 United States Based Cancer Targeted Drug Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cancer Targeted Drug Revenue, (2019-2024)
    4.4 China Based Companies Cancer Targeted Drug Revenue and Market Share, 2019-2024
        4.4.1 China Based Cancer Targeted Drug Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cancer Targeted Drug Revenue, (2019-2024)
    4.5 Rest of World Based Cancer Targeted Drug Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Cancer Targeted Drug Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Cancer Targeted Drug Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Cancer Targeted Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Sorafenib
        5.2.2 Lenvatinib
        5.2.3 Regorafenib
        5.2.4 Osimertinib
        5.2.5 Anlotinib
        5.2.6 Alectinib
        5.2.7 Other
    5.3 Market Segment by Type
        5.3.1 World Cancer Targeted Drug Market Size by Type (2019-2024)
        5.3.2 World Cancer Targeted Drug Market Size by Type (2025-2030)
        5.3.3 World Cancer Targeted Drug Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Cancer Targeted Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Retail Pharmacy
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Cancer Targeted Drug Market Size by Application (2019-2024)
        6.3.2 World Cancer Targeted Drug Market Size by Application (2025-2030)
        6.3.3 World Cancer Targeted Drug Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Bayer
        7.1.1 Bayer Details
        7.1.2 Bayer Major Business
        7.1.3 Bayer Cancer Targeted Drug Product and Services
        7.1.4 Bayer Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Bayer Recent Developments/Updates
        7.1.6 Bayer Competitive Strengths & Weaknesses
    7.2 Eisai
        7.2.1 Eisai Details
        7.2.2 Eisai Major Business
        7.2.3 Eisai Cancer Targeted Drug Product and Services
        7.2.4 Eisai Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Eisai Recent Developments/Updates
        7.2.6 Eisai Competitive Strengths & Weaknesses
    7.3 Zelgen
        7.3.1 Zelgen Details
        7.3.2 Zelgen Major Business
        7.3.3 Zelgen Cancer Targeted Drug Product and Services
        7.3.4 Zelgen Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Zelgen Recent Developments/Updates
        7.3.6 Zelgen Competitive Strengths & Weaknesses
    7.4 Cipla
        7.4.1 Cipla Details
        7.4.2 Cipla Major Business
        7.4.3 Cipla Cancer Targeted Drug Product and Services
        7.4.4 Cipla Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Cipla Recent Developments/Updates
        7.4.6 Cipla Competitive Strengths & Weaknesses
    7.5 Natco Pharma
        7.5.1 Natco Pharma Details
        7.5.2 Natco Pharma Major Business
        7.5.3 Natco Pharma Cancer Targeted Drug Product and Services
        7.5.4 Natco Pharma Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Natco Pharma Recent Developments/Updates
        7.5.6 Natco Pharma Competitive Strengths & Weaknesses
    7.6 AstraZeneca
        7.6.1 AstraZeneca Details
        7.6.2 AstraZeneca Major Business
        7.6.3 AstraZeneca Cancer Targeted Drug Product and Services
        7.6.4 AstraZeneca Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 AstraZeneca Recent Developments/Updates
        7.6.6 AstraZeneca Competitive Strengths & Weaknesses
    7.7 Novartis
        7.7.1 Novartis Details
        7.7.2 Novartis Major Business
        7.7.3 Novartis Cancer Targeted Drug Product and Services
        7.7.4 Novartis Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Novartis Recent Developments/Updates
        7.7.6 Novartis Competitive Strengths & Weaknesses
    7.8 Roche
        7.8.1 Roche Details
        7.8.2 Roche Major Business
        7.8.3 Roche Cancer Targeted Drug Product and Services
        7.8.4 Roche Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Roche Recent Developments/Updates
        7.8.6 Roche Competitive Strengths & Weaknesses
    7.9 Bristol-Myers Squibb
        7.9.1 Bristol-Myers Squibb Details
        7.9.2 Bristol-Myers Squibb Major Business
        7.9.3 Bristol-Myers Squibb Cancer Targeted Drug Product and Services
        7.9.4 Bristol-Myers Squibb Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Bristol-Myers Squibb Recent Developments/Updates
        7.9.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.10 Pfizer
        7.10.1 Pfizer Details
        7.10.2 Pfizer Major Business
        7.10.3 Pfizer Cancer Targeted Drug Product and Services
        7.10.4 Pfizer Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Pfizer Recent Developments/Updates
        7.10.6 Pfizer Competitive Strengths & Weaknesses
    7.11 BEACON Pharma
        7.11.1 BEACON Pharma Details
        7.11.2 BEACON Pharma Major Business
        7.11.3 BEACON Pharma Cancer Targeted Drug Product and Services
        7.11.4 BEACON Pharma Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 BEACON Pharma Recent Developments/Updates
        7.11.6 BEACON Pharma Competitive Strengths & Weaknesses
    7.12 Jiangxi Shanxiang
        7.12.1 Jiangxi Shanxiang Details
        7.12.2 Jiangxi Shanxiang Major Business
        7.12.3 Jiangxi Shanxiang Cancer Targeted Drug Product and Services
        7.12.4 Jiangxi Shanxiang Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Jiangxi Shanxiang Recent Developments/Updates
        7.12.6 Jiangxi Shanxiang Competitive Strengths & Weaknesses
    7.13 Yao Pharma
        7.13.1 Yao Pharma Details
        7.13.2 Yao Pharma Major Business
        7.13.3 Yao Pharma Cancer Targeted Drug Product and Services
        7.13.4 Yao Pharma Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Yao Pharma Recent Developments/Updates
        7.13.6 Yao Pharma Competitive Strengths & Weaknesses
    7.14 CSPC
        7.14.1 CSPC Details
        7.14.2 CSPC Major Business
        7.14.3 CSPC Cancer Targeted Drug Product and Services
        7.14.4 CSPC Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 CSPC Recent Developments/Updates
        7.14.6 CSPC Competitive Strengths & Weaknesses
    7.15 CHIATAI Tianqing
        7.15.1 CHIATAI Tianqing Details
        7.15.2 CHIATAI Tianqing Major Business
        7.15.3 CHIATAI Tianqing Cancer Targeted Drug Product and Services
        7.15.4 CHIATAI Tianqing Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 CHIATAI Tianqing Recent Developments/Updates
        7.15.6 CHIATAI Tianqing Competitive Strengths & Weaknesses
    7.16 Simcere
        7.16.1 Simcere Details
        7.16.2 Simcere Major Business
        7.16.3 Simcere Cancer Targeted Drug Product and Services
        7.16.4 Simcere Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 Simcere Recent Developments/Updates
        7.16.6 Simcere Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cancer Targeted Drug Industry Chain
    8.2 Cancer Targeted Drug Upstream Analysis
    8.3 Cancer Targeted Drug Midstream Analysis
    8.4 Cancer Targeted Drug Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Cancer Targeted Drug Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Cancer Targeted Drug Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Cancer Targeted Drug Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Cancer Targeted Drug Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Cancer Targeted Drug Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Cancer Targeted Drug Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Cancer Targeted Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Cancer Targeted Drug Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Cancer Targeted Drug Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Cancer Targeted Drug Players in 2023
    Table 12. World Cancer Targeted Drug Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Cancer Targeted Drug Company Evaluation Quadrant
    Table 14. Head Office of Key Cancer Targeted Drug Player
    Table 15. Cancer Targeted Drug Market: Company Product Type Footprint
    Table 16. Cancer Targeted Drug Market: Company Product Application Footprint
    Table 17. Cancer Targeted Drug Mergers & Acquisitions Activity
    Table 18. United States VS China Cancer Targeted Drug Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Cancer Targeted Drug Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Cancer Targeted Drug Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Cancer Targeted Drug Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Cancer Targeted Drug Revenue Market Share (2019-2024)
    Table 23. China Based Cancer Targeted Drug Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Cancer Targeted Drug Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Cancer Targeted Drug Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Cancer Targeted Drug Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Cancer Targeted Drug Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Cancer Targeted Drug Revenue Market Share (2019-2024)
    Table 29. World Cancer Targeted Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Cancer Targeted Drug Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Cancer Targeted Drug Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Cancer Targeted Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Cancer Targeted Drug Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Cancer Targeted Drug Market Size by Application (2025-2030) & (USD Million)
    Table 35. Bayer Basic Information, Area Served and Competitors
    Table 36. Bayer Major Business
    Table 37. Bayer Cancer Targeted Drug Product and Services
    Table 38. Bayer Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Bayer Recent Developments/Updates
    Table 40. Bayer Competitive Strengths & Weaknesses
    Table 41. Eisai Basic Information, Area Served and Competitors
    Table 42. Eisai Major Business
    Table 43. Eisai Cancer Targeted Drug Product and Services
    Table 44. Eisai Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Eisai Recent Developments/Updates
    Table 46. Eisai Competitive Strengths & Weaknesses
    Table 47. Zelgen Basic Information, Area Served and Competitors
    Table 48. Zelgen Major Business
    Table 49. Zelgen Cancer Targeted Drug Product and Services
    Table 50. Zelgen Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Zelgen Recent Developments/Updates
    Table 52. Zelgen Competitive Strengths & Weaknesses
    Table 53. Cipla Basic Information, Area Served and Competitors
    Table 54. Cipla Major Business
    Table 55. Cipla Cancer Targeted Drug Product and Services
    Table 56. Cipla Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Cipla Recent Developments/Updates
    Table 58. Cipla Competitive Strengths & Weaknesses
    Table 59. Natco Pharma Basic Information, Area Served and Competitors
    Table 60. Natco Pharma Major Business
    Table 61. Natco Pharma Cancer Targeted Drug Product and Services
    Table 62. Natco Pharma Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Natco Pharma Recent Developments/Updates
    Table 64. Natco Pharma Competitive Strengths & Weaknesses
    Table 65. AstraZeneca Basic Information, Area Served and Competitors
    Table 66. AstraZeneca Major Business
    Table 67. AstraZeneca Cancer Targeted Drug Product and Services
    Table 68. AstraZeneca Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. AstraZeneca Recent Developments/Updates
    Table 70. AstraZeneca Competitive Strengths & Weaknesses
    Table 71. Novartis Basic Information, Area Served and Competitors
    Table 72. Novartis Major Business
    Table 73. Novartis Cancer Targeted Drug Product and Services
    Table 74. Novartis Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Novartis Recent Developments/Updates
    Table 76. Novartis Competitive Strengths & Weaknesses
    Table 77. Roche Basic Information, Area Served and Competitors
    Table 78. Roche Major Business
    Table 79. Roche Cancer Targeted Drug Product and Services
    Table 80. Roche Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Roche Recent Developments/Updates
    Table 82. Roche Competitive Strengths & Weaknesses
    Table 83. Bristol-Myers Squibb Basic Information, Area Served and Competitors
    Table 84. Bristol-Myers Squibb Major Business
    Table 85. Bristol-Myers Squibb Cancer Targeted Drug Product and Services
    Table 86. Bristol-Myers Squibb Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Bristol-Myers Squibb Recent Developments/Updates
    Table 88. Bristol-Myers Squibb Competitive Strengths & Weaknesses
    Table 89. Pfizer Basic Information, Area Served and Competitors
    Table 90. Pfizer Major Business
    Table 91. Pfizer Cancer Targeted Drug Product and Services
    Table 92. Pfizer Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Pfizer Recent Developments/Updates
    Table 94. Pfizer Competitive Strengths & Weaknesses
    Table 95. BEACON Pharma Basic Information, Area Served and Competitors
    Table 96. BEACON Pharma Major Business
    Table 97. BEACON Pharma Cancer Targeted Drug Product and Services
    Table 98. BEACON Pharma Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. BEACON Pharma Recent Developments/Updates
    Table 100. BEACON Pharma Competitive Strengths & Weaknesses
    Table 101. Jiangxi Shanxiang Basic Information, Area Served and Competitors
    Table 102. Jiangxi Shanxiang Major Business
    Table 103. Jiangxi Shanxiang Cancer Targeted Drug Product and Services
    Table 104. Jiangxi Shanxiang Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. Jiangxi Shanxiang Recent Developments/Updates
    Table 106. Jiangxi Shanxiang Competitive Strengths & Weaknesses
    Table 107. Yao Pharma Basic Information, Area Served and Competitors
    Table 108. Yao Pharma Major Business
    Table 109. Yao Pharma Cancer Targeted Drug Product and Services
    Table 110. Yao Pharma Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Yao Pharma Recent Developments/Updates
    Table 112. Yao Pharma Competitive Strengths & Weaknesses
    Table 113. CSPC Basic Information, Area Served and Competitors
    Table 114. CSPC Major Business
    Table 115. CSPC Cancer Targeted Drug Product and Services
    Table 116. CSPC Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 117. CSPC Recent Developments/Updates
    Table 118. CSPC Competitive Strengths & Weaknesses
    Table 119. CHIATAI Tianqing Basic Information, Area Served and Competitors
    Table 120. CHIATAI Tianqing Major Business
    Table 121. CHIATAI Tianqing Cancer Targeted Drug Product and Services
    Table 122. CHIATAI Tianqing Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 123. CHIATAI Tianqing Recent Developments/Updates
    Table 124. Simcere Basic Information, Area Served and Competitors
    Table 125. Simcere Major Business
    Table 126. Simcere Cancer Targeted Drug Product and Services
    Table 127. Simcere Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 128. Global Key Players of Cancer Targeted Drug Upstream (Raw Materials)
    Table 129. Cancer Targeted Drug Typical Customers
List of Figure
    Figure 1. Cancer Targeted Drug Picture
    Figure 2. World Cancer Targeted Drug Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Cancer Targeted Drug Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Cancer Targeted Drug Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Cancer Targeted Drug Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Cancer Targeted Drug Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Cancer Targeted Drug Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Cancer Targeted Drug Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Cancer Targeted Drug Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Cancer Targeted Drug Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Cancer Targeted Drug Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Cancer Targeted Drug Revenue (2019-2030) & (USD Million)
    Figure 13. Cancer Targeted Drug Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Cancer Targeted Drug Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Cancer Targeted Drug by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Cancer Targeted Drug Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Cancer Targeted Drug Markets in 2023
    Figure 27. United States VS China: Cancer Targeted Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Cancer Targeted Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Cancer Targeted Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Cancer Targeted Drug Market Size Market Share by Type in 2023
    Figure 31. Sorafenib
    Figure 32. Lenvatinib
    Figure 33. Regorafenib
    Figure 34. Osimertinib
    Figure 35. Anlotinib
    Figure 36. Alectinib
    Figure 37. Other
    Figure 38. World Cancer Targeted Drug Market Size Market Share by Type (2019-2030)
    Figure 39. World Cancer Targeted Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 40. World Cancer Targeted Drug Market Size Market Share by Application in 2023
    Figure 41. Hospital
    Figure 42. Retail Pharmacy
    Figure 43. Other
    Figure 44. Cancer Targeted Drug Industrial Chain
    Figure 45. Methodology
    Figure 46. Research Process and Data Source

Companies Mentioned

Bayer
Eisai
Zelgen
Cipla
Natco Pharma
AstraZeneca
Novartis
Roche
Bristol-Myers Squibb
Pfizer
BEACON Pharma
Jiangxi Shanxiang
Yao Pharma
CSPC
CHIATAI Tianqing
Simcere